Market Analysis

The Middle East and Africa intravenous equipment market is expanding steadily as healthcare systems across the region enhance infrastructure, increase healthcare spending, and prioritize improved clinical outcomes for acute and chronic conditions that require effective intravenous therapy such as fluid replacement, drug delivery, parenteral nutrition and blood transfusions. Key markets in the region including Saudi Arabia, the United Arab Emirates, South Africa, Egypt and Nigeria are driving demand for a wide range of IV devices including infusion pumps, catheters, administration sets, securement devices and safety products because of rising prevalence of non communicable diseases, increasing surgical procedures, expanding critical care capacity and growing adoption of homecare and outpatient services. Regulatory oversight in the Middle East and Africa varies by country but is strengthening as governments seek alignment with international safety and quality standards. National health authorities in Gulf Cooperation Council countries, for example, require stringent device registration, conformity assessments and quality management system compliance from manufacturers before intravenous equipment can be marketed. In some African countries regulatory frameworks are evolving with support from regional harmonization initiatives and international partners aimed at improving medical device safety, post market surveillance and reporting. Government policies in several nations emphasize healthcare modernization, infection control and needlestick injury prevention, which create impetus for adoption of advanced IV technologies including closed systems, needleless connectors and smart infusion pumps. According to the research report, "Middle East and Africa Intravenous Equipment Market Research Report, 2031," published by Actual Market Research, the Middle East and Africa Intravenous Equipment market is anticipated to grow at more than 7.50% CAGR from 2026 to 2031. As global manufacturers such as Becton Dickinson, B. Braun, Fresenius Kabi, Terumo, ICU Medical and Baxter seek to increase their footprint in the region, they engage in partnerships with regional distributors and local healthcare providers to enhance product availability, navigate regulatory requirements and tailor solutions to meet the unique needs of individual markets. Joint ventures and distribution agreements help these companies introduce a broader portfolio of infusion pumps, safety devices, integrated closed systems and securement products across public and private hospital networks. Some collaboration also focus on training initiatives that educate clinicians on best practices for vascular access management, infection prevention and safe device operation, which improves adoption rates and clinical outcomes.

Mergers and acquisitions involving local medical device firms and international players strengthen technology transfer, expand production capacity and improve supply chain resilience in the region, enabling more competitive pricing and faster delivery of critical intravenous equipment. The import and export trade dynamics in the Middle East and Africa reflect significant flows of raw materials and finished products, with finished IV devices often imported from manufacturing hubs in Europe, North America and Asia due to limited regional production capabilities for sophisticated medical technology. Key imported components include medical grade polymers, precision electronics, sensor modules, sterile packaging materials and smart software systems, which are assembled into final products either abroad or in regional hubs such as the UAE or South Africa for distribution across neighboring markets. .

Market Dynamic

Segmentation

Intravenous securement devices are the fastest growing by product type in the Middle East and Africa intravenous equipment market because they play a critical role in improving patient safety by reducing catheter related complications.

As healthcare providers respond to a rising burden of chronic diseases such as cancer diabetes and cardiovascular disorders which require frequent and long term intravenous access there is heightened demand for reliable methods to stabilise intravenous lines securely during prolonged therapies to minimise risks such as catheter dislodgement phlebitis and bloodstream infections that can compromise treatment outcomes and increase care costs. Securement devices provide a tangible clinical advantage over traditional fixation methods because they are specifically engineered to maintain catheter placement reduce micro movements at the insertion site and lower the incidence of healthcare associated infections which are a significant concern in both acute and long term care settings with stringent infection control protocols being adopted widely across hospitals and clinics in key MEA markets. This emphasis on patient safety and adherence to infection prevention standards means healthcare institutions are increasingly investing in advanced securement solutions that feature improved adhesives biocompatible materials and ergonomic designs that enhance comfort and reduce skin irritation for patients while also simplifying application and management for clinical staff. Furthermore the rapid development of healthcare infrastructure throughout the Middle East particularly in the Gulf Cooperation Council states and urban centres in Africa is enabling broader deployment of sophisticated intravenous therapy technologies including securement devices as part of comprehensive vascular access kits.

Hospitals and clinics, including dialysis centers, dominate the Middle East and Africa intravenous equipment market as they serve as primary care facilities delivering the highest volumes of IV therapies.

Hospitals and clinics treat a high volume of patients requiring fluid therapy, medication infusions, blood transfusions, nutritional support, and dialysis procedures often simultaneously across intensive care units, emergency departments, surgical suites, oncology wards, and general wards, which drives substantial demand for a full range of intravenous products including infusion pumps, catheters, administration sets, and related accessories. Evidence from market reports indicates that hospitals account for the largest share of the market as they maintain continuous utilization of IV equipment due to the complex and urgent nature of many cases, and the need for precise control and monitoring that can only be provided in institutional settings where trained personnel and advanced support systems. Hospitals serve as the principal consumer group because they handle an escalating number of hospital admissions driven by the rising prevalence of non-communicable diseases such as diabetes, cardiovascular disorders, cancer, and kidney failure, which often lead to complications that necessitate intravenous interventions and prolonged dialysis support. These chronic health burdens are increasing across the Middle East and Africa and require complex treatments that cannot be easily managed in homecare or ambulatory settings for many patients, especially those with severe symptoms or multiple comorbidities.

Integrated and closed systems are the fastest-growing technology segment in the Middle East and Africa intravenous equipment market because they enhance patient safety and improve workflow efficiency in modern healthcare facilities.

Unlike traditional open IV systems, integrated and closed systems minimize the number of manual connections and disconnections required, thereby significantly reducing the chances of catheter-related bloodstream infections and other complications associated with improper handling. The emphasis on patient safety has become a top priority for healthcare providers in the region, particularly in critical care units, surgical wards, oncology departments, and dialysis centers, where intravenous therapy is frequent and high-risk. Hospitals and clinics in countries such as Saudi Arabia, the United Arab Emirates, Egypt, and South Africa are increasingly implementing these technologies as part of standardized infection control protocols to meet international healthcare standards and enhance overall clinical outcomes. Patients with long-term intravenous therapy requirements, such as chemotherapy, parenteral nutrition, or dialysis, benefit from the reliability and safety of closed systems, which maintain aseptic conditions, reduce line dislodgement, and improve dwell times. The systems also contribute to operational efficiency by streamlining workflows for nurses and healthcare professionals, allowing them to focus on patient care rather than device assembly or troubleshooting. This efficiency is especially valuable in high-volume healthcare settings that face increasing patient loads due to rising population and urbanization in the region. Government initiatives and healthcare infrastructure modernization efforts in the Middle East and Africa are also accelerating the adoption of integrated and closed systems. Investments under national healthcare plans, such as Saudi Arabia’s Vision 2030 and UAE health sector development programs, focus on upgrading hospitals, improving infection control standards, and promoting the use of advanced medical devices that align with global best practices.

Market Regional Insights

Saudi Arabia is the largest market for intravenous equipment in the Middle East and Africa because of its advanced healthcare infrastructure and government initiatives aimed at improving patient care.

The country has made significant investments in healthcare infrastructure under its Vision 2030 initiative, which aims to modernize the healthcare system, expand hospital networks, and improve access to quality care for its population. These investments have led to the establishment of modern hospitals, specialized clinics, and tertiary care centers that require a wide range of intravenous equipment, including infusion pumps, catheters, administration sets, and securement devices. The presence of advanced medical facilities ensures that intravenous therapies are administered according to international standards and that the adoption of sophisticated technologies, such as smart infusion systems and closed IV systems, is both feasible and encouraged. The rising prevalence of chronic diseases such as diabetes, cancer, cardiovascular disorders, and renal conditions has further increased the demand for intravenous therapy and related equipment, as these conditions often require long-term fluid management, medication delivery, and dialysis support. The Ministry of Health has been implementing initiatives to enhance the quality of care, reduce hospital-acquired infections, and increase the efficiency of treatment delivery. These initiatives encourage healthcare providers to use high-quality intravenous equipment that supports accurate dosing, fluid management, and infection prevention. The regulatory framework in Saudi Arabia also ensures that medical devices meet rigorous safety and performance standards, which helps increase confidence in IV equipment and supports higher adoption rates.